Navigating 6 Analyst Ratings For Moderna
Navigating 6 Analyst Ratings For Moderna
瀏覽 Moderna 的 6 個分析師評級
In the preceding three months, 6 analysts have released ratings for Moderna (NASDAQ:MRNA), presenting a wide array of perspectives from bullish to bearish.
在過去的三個月中，有6位分析師發佈了Moderna（納斯達克股票代碼：MRNA）的評級，提出了從看漲到看跌的各種觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他們最近的評級，簡要介紹了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $119.17, a high estimate of $163.00, and a low estimate of $86.00. This upward trend is apparent, with the current average reflecting a 19.56% increase from the previous average price target of $99.67.
分析師分析的12個月目標股價提供了見解，平均目標股價爲119.17美元，最高估計爲163.00美元，低估值爲86.00美元。這種上升趨勢顯而易見，當前的平均價格比之前的平均目標價99.67美元上漲了19.56％。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：仔細觀察
The standing of Moderna...
通過對分...
登入免費觀看全文
登入/註冊